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AbstrACt
background Universal health coverage (UHC) is difficult 
to achieve in settings short of medicines, health workers 
and health facilities. These characteristics define the 
majority of the small island developing states (SIDS), where 
population size negates the benefits of economies of scale. 
One option to alleviate this constraint is to import health 
services, rather than focus on domestic production. This 
paper provides empirical analysis of the potential impact of 
this option.
Methods Analysis was based on publicly accessible data 
for 14 SIDS, covering health-related travel and health 
indicators for the period 2003–2013, together with in-
depth review of medical travel schemes for the two highest 
importing SIDS—the Maldives and Tuvalu.
Findings Medical travel from SIDS is accelerating. The 
SIDS studied generally lacked health infrastructure and 
technologies, and the majority of them had lower than 
the recommended number of physicians in a country, 
which limits their capacity for achieving UHC. Tuvalu and 
the Maldives were the highest importers of healthcare 
and notably have public schemes that facilitate medical 
travel and help lower the out-of-pocket expenditure on 
medical travel. Although different in approach, design and 
performance, the medical travel schemes in Tuvalu and the 
Maldives are both examples of measures used to increase 
access to health services that cannot feasibly be provided 
in SIDS.
Interpretation Our findings suggest that importing health 
services (through schemes to facilitate medical travel) is a 
potential mechanism to help achieve universal healthcare 
for SIDS but requires due diligence over cost, equity and 
quality control.
IntroduCtIon
Universal health coverage (UHC) refers to a 
healthcare system that provides coverage of 
quality healthcare and financial protection 
to all citizens of a country.1 It has become 
the globally accepted concept for advocating 
access to, and affordability of, healthcare 
and is recognised in the Sustainable Devel-
opment Goals.2 For countries to achieve 
UHC, a set of prerequisites are needed, such 
as political will and stakeholder support for 
predominantly public sector funding.3 The 
WHO also proposes four essential attributes 
for achieving UHC: an efficient and well-run 
health system; an affordable and equitable 
system for financing; access to essential medi-
cines and technologies; and a sufficiently 
trained and motivated health workforce.3 
Shortages of medicines, health workers and 
health facilities are major impediments to 
Key questions
What is already known about this topic?
 ► Much analysis of the medical travel market has 
identified that medical travel is growing, although at 
a slower pace than originally projected.
 ► A systematic review of medical travel literature 
observed that the effects on the originating 
(importing) countries’ health system were mainly 
perceived as negative. These include patients 
returning with complications, rising costs and lack 
of regulation in the industry.
 ► However, findings across the different studies 
suggested that the impact on a country’s health 
system depends on the context and capacity.
What are the new findings?
 ► The multicountry analysis presented here is the first 
of medical travel among small island developing 
states (SIDS), and the findings confirm that the 
import of health services among SIDS has occurred 
at a slower pace than the projected rise of the 
global medical travel industry.
 ► The non-linear growth of medical travel among 
SIDS gives evidence that the industry is volatile to 
external shocks, which is a factor that needs to be 
taken into consideration by SIDS considering import 
as a mechanism to increase access to health 
services.
 ► While existing literature notes the scarcity of 
institutionalised arrangements for medical 
travel, our findings highlight the success of three 
government-funded schemes among SIDS. The 
Tuvalu Medical Treatment Scheme spent 44.5% 
of its health budget on overseas treatment in 
2013, while the Maldivian government spent 
$11.6 million on subsidised medical travel in 
2012 and highly specialised treatment worth 
$1.53 million per annum was funded by the 
Seychelles government.
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moving towards UHC and are characteristics that typify 
most small island developing states (SIDS). Thirty-nine 
countries are defined as SIDS, characterised by their 
narrow economic base, high production costs, shortage 
of skilled labour and heavy dependence on trade and 
foreign aid.4 5 The majority of SIDS receive high levels 
of overseas development assistance, and bilateral and 
multilateral trade has been one strategy that SIDS have 
used to overcome domestic shortages.6 While there 
are benefits to trade, there is a clear need for caution 
when liberalising trade, including healthcare. Walls et 
al7 highlight that trade negotiations themselves, and the 
ongoing management of trade agreements once signed, 
can become a burden on the governments of smaller and 
poorer states. Yet, there is a dearth of systematic cata-
loguing and analysis of trade policy initiatives and their 
impact on health systems, leaving an incomplete picture 
of their nature and effects.8 This is especially true when it 
comes to SIDS, and this is the gap that this paper seeks to 
fill through the comparative analysis of the experience of 
a large group of SIDS.
Cross-country comparison of health system perfor-
mance, if undertaken appropriately, can provide a 
powerful method for identifying strengths and weak-
nesses of reforms relevant to similar settings.9 This paper 
presents a cross-country comparison focused on medical 
travel to understand the pattern of consumption of 
health services abroad by SIDS, mapping the linkages 
between the import of health services and the health 
indicators relevant to achieving UHC. On this basis, we 
analyse how import of services through public medical 
travel schemes affects access to quality health services and 
UHC for SIDS.
MetHods
study design
Quantitative analysis was conducted on sets of longitu-
dinal secondary data on health-related travel and health 
indicators covering the period 2003–2013. A review of 
policy documents was used to understand, where possible, 
the reasons for the observed trends and patterns iden-
tified by the quantitative analysis. The study covered all 
SIDS that are member states of the UN and that reported 
health-related travel data to the International Monetary 
Fund (IMF), which are presented in table 1.
We developed a framework for analysis based on the 
WHO building blocks framework (2007),10 reflecting the 
four core dimensions of UHC (table 2). Two health indi-
cators per dimension were selected, based primarily on 
data availability. To understand the relationship between 
each dimension of UHC and the import of health 
services, each pair of indicators was then mapped onto 
the outcome variable ‘health-related travel expenditure 
(HRT)’, for the period 2003–2013.
Sources of data
Data for the study were obtained from three sources: the 
IMF, the World Bank (WB) and the WHO. Data addressing 
the main outcome variable, ‘Health-related travel expend-
iture $’ were obtained from the IMF databank online. 
From the annually published balance of payments (BOP) 
data by the IMF, the item ‘Health-related travel expendi-
tures (personal) in current USD’ was acquired for the years 
2003–2013 for all the SIDS that reported these data. In the 
BOP, the item is presented under ‘Current Account/Goods 
and Services/Services/Travel/Personal/Health related, 
Debit, US Dollars’ for expenditures. According to the BOP 
manual, the travel component covers the goods and services 
acquired from an economy by travellers during visits of less 
than 1 year in that economy.11 Four broad approaches are 
used by Member States to measure travel expenditure, and 
the table in online supplementary annex 1 summarises the 
sources and methodologies used by the selected SIDS to 
report health-related travel data to the IMF. The WB data 
bank provided country-level indicators for the years 2003–
2013 on health expenditure public (as a proportion of total 
health expenditure (THE)) (2003–2013), and out-of-pocket 
expenditure (OOP) health expenditure (as a proportion 
of THE) (2003–2013), while statistics from WHO (2015) 
were used to obtain indicators on health infrastructures and 
health technologies, health personnel and service coverage 
indicators. The two highest importers having the steepest 
rises in per capita HRT during the study period were 
selected, and policy documents relating to these two coun-
tries by three international donor agencies (WHO, WB and 
IMF) were reviewed (table 3 summarises the documents 
reviewed for each country).
Data management and analysis
The unit of analysis is the country. HRT per capita was 
derived by dividing HRT by the total population for each 
year. Median, IQR and percentages were used to describe 
data. Bubble charts that can show the relation between 
three different sets of variables were used to map the link-
ages between health indicators and health-related travel. 
Where indicator data were available for a certain year(s), 
the HRT data in the bubble represent the same year(s) as 
the indicators on the x and y axes. In this analysis, the x and 
y axes present the related indicators, and the data points 
represent the location of the country with regard to the 
indicators on the axes. The size of the bubble represents 
the amount spent on medical travel against the backdrop 
of each system needed for UHC. For instance, countries 
Key questions
recommendations for policy
 ► In settings with small health systems and extreme resource 
constraints, state- led strategic importing of health services 
using regional integration could be a potential mechanism to help 
achieve universal health coverage in SIDS. However, appropriate 
due diligence over cost, equity and quality control needs to be 
taken to minimise the perceived negative consequences from this 
trade.
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scoring high on skilled birth Attendents (SBA) and ante-
natal care  (ANC) indicators show a strong, efficient and 
well-run domestic health system, while the size of the bubble 
would be an implication of the deficiencies in that system.
Role of the funding source
The funding source did not have any involvement in 
the design, collection, analysis and interpretation of 
the data presented in the paper or in the decision to 
submit the paper for publication. However, the salary of 
the corresponding author was covered by the funding 
source. The corresponding author confirms that she 
had full access to all the data in the study and had final 
responsibility for the decision to submit for publication.
results
Fourteen of the 39 SIDS reported health-related travel 
data to the IMF. As shown in figure 1, a rising trend 
was observed in health-related travel expenses over the 
Table 1 Characteristics of small island developing states (SIDS)
SIDS by WHO 
region
Land area 
(sq. km)
Total 
population
Health 
expenditure 
per capita $
Net ODA 
per capita 
(current $)
Trade in 
services as 
% of GDP Top 5 import partners 2014
2013 2013 2013 2013 2013 n=total number of import partners
Regional officie for 
the Western Pacific 
(WPRO)
  Fiji 18 270 880 487 189 103 46.38 n=168, Singapore, Australia, New 
Zealand, China, France
  Marshall Islands 180 52 786 630 1776 South Korea, China, Germany, Turkey 
and Poland
  Tonga 720 105 139 204 764 34.55 (2012) n=86, New Zealand, Singapore, USA, 
Japan, Fiji
  Tuvalu 30 9876 704 2703 110.27 (2008) n=28, Fiji, Australia, New Zealand, 
Japan, other Asian countries
  Vanuatu 12 190 253 165 123 358 54.40 (2011) n=99, Australia, Singapore, New 
Zealand, Fiji, China
Pan 
AmericanHealth 
Organisation 
  Bahamas 10 010 377 841 1621 49.53 n=100, USA, Barbados, Trinidad 
&Tobago, Japan
  Belize 22 810 344 193 262 144 40.38 n=120, USA, Curacao, Mexico, China, 
Guatemala
  Barbados 430 282 503 1007 53.36 (2010) n=177, USA, Trinidad & Tobago, 
China, UK, Suriname
AFRO
  Cape Verde 4030 507 258 165 480 56.02 n=101, Portugal, The Netherlands, 
Spain, Brazil, China
  Comoros 1861 751 697 51 109 27.26 (2009) n=79, UAE, France, Pakistan, China, 
South Africa
  Guinea-Bissau 28 120 1 757 138 32 59 7.9 (2005) n=24, Senegal, Portugal, Thailand, 
The Netherlands, France
  Sao Tome and 
Principe
960 182 386 110 284 39.21 n=63, Portugal, Angola, China, USA, 
Gabon
  Seychelles 455 89 900 551 283 73.17 (2008) n=160, UAE, Saudi Arabia, Singapore, 
Germany, France
South East Asia 
Region
  Maldives 300 393 000 720 58 116.69 n=87, UAE, Singapore, India, 
Malaysia, Sri Lanka
Source: The World Bank.30 31
AFRO,  r egional office for Africa; GDP, gross domestic product; ODA, overseas development assistance;    PAHO, Pan American Health 
Organisation; SEAR, South East Asia Region; WPRO, regional office for Western Pacific.
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10-year period across the 14 countries. Median expendi-
tures across the countries rose 4.5 times between 2003 
and 2013, from $0.68 to $3.11 million, while a few SIDS 
were found to have extremely high per capita expendi-
ture (figure 2).
Although expenditure on health-related travel by the 
SIDS increased over time, it was not linear for any country. 
Notable fluctuations in medical travel were observed for 
many countries, particularly from 2009 to 2012, which 
may reflect issues of data quality or reporting. By 2013, 
Tuvalu, the Maldives and the Seychelles were observed to 
be the top importers of health services among the SIDS. 
While it is beyond the scope of this paper to explore the 
individual travel growth patterns of SIDS, we examined 
the relationship between health-related travel and health 
systems of these countries.
Table 4 indicates that all SIDS perform well on the 
service coverage indicators that were used to represent 
a well-running health system, except for Guinea Bissau, 
which had very low access to skilled birth attendance. In 
health financing, WPRO SIDS generally perform better 
than other regions with high public expenditure and very 
low OOP. Tuvalu had almost 100% of its health expen-
ditures borne by the government. Health infrastruc-
tures and technologies range on average 1–10 hospitals 
per 100 000 populations and 0–13 CTs per one million 
populations respectively. Access to health workforce were 
lowest in Guinea Bissau (0.7 and 5.9) and Cape Verde 
(3.1 and 5.6), while it was highest in Bahamas (28.2 and 
41.4).
Figures 3–6 show HRTs among SIDS mapped across the 
health systems indicators identified for UHC dimensions 
in our framework.
Mapped across the health service coverage indica-
tors, all SIDS were seen to perform well on coverage. 
The Maldives and Tuvalu, represented by the largest 
two bubbles, are observed to perform better on service 
indicators than the lowest importers of health services 
(Comoros and Vanuatu). Outliers Guinea Bissau and 
Vanuatu, which had lower levels of service coverage 
compared with other SIDS, also experienced low levels of 
import of health services.
A more linear pattern was observed between the public 
health expenditure and OOP health expenditure. Two 
large bubbles (the Maldives and Bahamas) were found 
at high levels of OOP spending. The largest bubble 
representing Tuvalu had very high levels of public health 
spending and very low OOP spending. Among the 
lowest importers of health services, Vanuatu had a very 
low OOP and high public expenditure on health, while 
Comoros’s health financing indicators were very low on 
both indicators.
Table 2 Indicators addressing key health system attributes for universal healthcare
Systems required for UHC Indicators Source
A strong, efficient, well-run health 
system
Births attended by skilled health personnel (%) 
(2007–2014)
Antenatal care coverage at least four visits (%) 
(2007–2014)
World health statistics, WHO 
201532
A system for financing health 
services
Health expenditure public (as a % of THE) (2003–
2013)
OOP health expenditure (as a % of THE) (2003–2013)
World Bank databank, 201630
Access to essential medicines and 
technologies
Density of hospitals per 1000 population (2013)
Density of CT units (CTs) per million population 
(2013)
World health statistics, WHO 2015
A sufficient capacity of well-trained, 
motivated health workers
Number of physicians per 10 000 population (2007–
2013)
Number of nursing and midwifery personnel per 
10 000 population (2007–2013)
World health statistics, WHO 2015
OOP, out-of-pocket expenditure; THE, total health expenditure; UHC, universal health coverage.
Table 3 Sources of data for qualitative analysis
Region Selected country Policy documents analysed Country reviews by WHO and WB
WPRO Tuvalu Tuvalu Strategic Health plan 2009–2018,27 
Medical treatment scheme guideline, NHA
WHO: country cooperation strategy 
brief (May 2014),33 Statement of the IMF 
Mission28
SEAR Maldives NHA 2011,34 Health master plan 2016–2025 WB: Maldives Health Policy Note (March 
2013)35
WHO: country cooperation strategy brief 
2013–201736
IMF, International Monetary Fund; WB, World Bank.
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Health-related travel mapped across the health 
workforce indicators showed that the largest bubbles 
were located at higher levels of nursing and midwifery 
personnel and around 10–15 physicians per 1000 popu-
lation. The Bahamas and the Marshall Islands had very 
contrasting levels of health workforce but experienced 
Figure 1 Trend of expenditure on health-related travel among 14 SIDS, 2003–2013. SIDS, small island developing states.
Figure 2 Per capita health-related travel expenditures among 14 small island developing states, 2003–2013.
group.bmj.com on February 28, 2018 - Published by http://gh.bmj.com/Downloaded from 
6 Suzana M, et al. BMJ Glob Health 2018;3:e000612. doi:10.1136/bmjgh-2017-000612
BMJ Global Health
Ta
b
le
 4
 
P
er
fo
rm
an
ce
 o
f S
ID
S
 a
cr
os
s 
sy
st
em
s 
re
q
ui
re
d
 fo
r 
U
H
C
S
ID
S
 b
y 
W
H
O
 
re
g
io
ns
In
d
ic
at
o
rs
A
 s
tr
o
ng
, e
ffi
ci
en
t,
 w
el
l-
ru
n 
he
al
th
 
sy
st
em
A
 s
ys
te
m
 f
o
r 
fi
na
nc
in
g
 h
ea
lt
h 
se
rv
ic
es
A
cc
es
s 
to
 e
ss
en
ti
al
 m
ed
ic
in
es
 a
nd
 
te
ch
no
lo
g
ie
s
A
 s
uf
fi
ci
en
t 
ca
p
ac
it
y 
o
f 
w
el
l-
tr
ai
ne
d
, m
o
ti
va
te
d
 h
ea
lt
h 
w
o
rk
er
s
B
ir
th
s 
at
te
nd
ed
 
b
y 
sk
ill
ed
 h
ea
lt
h 
p
er
so
nn
el
* 
(%
)
A
nt
en
at
al
 c
ar
e 
co
ve
ra
g
e 
at
 
le
as
t 
o
ne
 v
is
it
* 
(%
)
†H
ea
lt
h 
ex
p
en
d
it
ur
e 
p
ub
lic
 (a
s 
a 
%
 o
f 
T
H
E
)†
 
O
O
P
 h
ea
lt
h 
ex
p
en
d
it
ur
e 
(a
s 
a 
%
 o
f 
T
H
E
)†
 
D
en
si
ty
 o
f 
ho
sp
it
al
s 
p
er
 1
00
 0
00
 
p
o
p
ul
at
io
n*
D
en
si
ty
 o
f 
C
T
 
un
it
s 
p
er
 m
ill
io
n 
p
o
p
ul
at
io
n*
N
um
b
er
 o
f 
p
hy
si
ci
an
s 
p
er
 1
0 
00
0 
p
o
p
ul
at
io
n*
N
um
b
er
 o
f 
nu
rs
in
g
 a
nd
 
m
id
w
ife
ry
 
p
er
so
nn
el
 
p
er
 1
0 
00
0 
p
o
p
ul
at
io
n*
20
07
–2
01
4
20
07
–2
01
4
20
03
–2
01
3
20
03
–2
01
3
20
13
20
13
20
07
–2
01
3
20
07
–2
01
3
W
P
R
O
*(
re
gi
on
al
 
av
er
ag
e)
96
95
63
.5
15
.5
26
.2
 
    F
iji
99
98
73
.6
17
.0
8
‡2
.8
3.
4
4.
3
22
.4
 
    M
ar
sh
al
l 
Is
la
nd
s
90
92
84
.2
5
11
.8
4
3.
8
19
4.
4
17
.4
 
   To
ng
a
96
99
82
.2
1
11
.7
8
3.
8
0
5.
6
38
.8
 
   Tu
va
lu
93
93
99
.9
0.
1
10
.1
10
.9
58
.2
 
    V
an
ua
tu
89
76
82
.8
6
10
.9
2
2.
4
0
1.
2
17
PA
H
O
*(
re
gi
on
al
 
av
er
ag
e)
96
96
49
.0
21
.5
44
.9
 
    B
ah
am
as
99
86
46
.1
2
28
.3
8
1.
1
13
.2
28
.2
41
.4
 
   B
el
iz
e
95
96
62
.6
3
27
.7
5
2.
1
12
.1
8.
3
19
.6
 
    B
ar
b
ad
os
99
93
64
.4
8
28
.7
1.
1
7
A
FR
O
*(
re
gi
on
al
 
av
er
ag
e)
51
77
50
.8
0.
8
0.
4
2.
7
12
.4
 
   C
ap
e 
Ve
rd
e
99
91
74
.9
2
23
.1
5
1
2
3.
1
5.
6
 
   C
om
or
os
82
92
44
.7
8
45
.8
4
0.
7
1.
4
 
   G
ui
ne
a-
B
is
sa
u
43
93
22
.7
43
.8
9
56
.4
0
0.
7
5.
9
 
   S
ao
 T
om
e 
an
d
 
P
rin
ci
p
e
81
98
36
.5
8
49
.5
 
    S
ey
ch
el
le
s
99
91
.8
7
5.
77
1.
1
10
.8
10
.7
48
.1
S
E
A
R
*(
re
gi
on
al
 
av
er
ag
e)
68
77
37
.9
5.
9
15
.3
 
   M
al
d
iv
es
99
99
59
.4
2
31
.4
8
6.
7
5.
8
14
.2
50
.4
C
on
tin
ue
d
group.bmj.com on February 28, 2018 - Published by http://gh.bmj.com/Downloaded from 
Suzana M, et al. BMJ Glob Health 2018;3:e000612. doi:10.1136/bmjgh-2017-000612 7
BMJ Global Health
similar levels of HRT. The majority of the bubbles were 
located where health workforce was lower than 13.9 
physicians and 28.6 nursing personnel per 10 000 popula-
tion, which are the global averages for the two indicators. 
Thus, these countries have lower than the recommended 
WB ratio of 23 doctors, nurses and midwives per 100 000.
Based on the two indicators used to represent health 
infrastructures and medical technology, all SIDS faced 
shortages in health infrastructure and technologies that 
may reflect the small populations these countries serve. 
Both large and small bubbles were located where hospi-
tals per 100 000 population were less than 10 and access to 
technologies were less than 20 units per 1 million popu-
lation. These were however above the global medians of 
1.1 hospital per 100 000 population and 3.8 units per 1 
million population.
Table 5 provides a description of medical travel 
schemes in the two SIDS, Tuvalu and the Maldives, which 
the quantitative analysis demonstrated had the highest 
and most fluctuating trends during the study period. It 
shows that through medical travel, both the Maldives and 
Tuvalu appear to have increased access to health services 
unavailable within each country previously, which may 
have been spent from out-of-pocket. With the govern-
ment directly approaching foreign health providers, the 
Maldives compared with Tuvalu is found to be providing 
a more comprehensive set of services to a greater number 
of patients at a smaller per capita health budget. However, 
the multilateral approach by Tuvalu has the ability to 
reduce the burden of OOP as it covers the full cost of 
travel episode and offers services of foreign specialists 
through the scheme.
dIsCussIon
Based on analysis of 14 SIDS, there appears to be a gradual 
but fluctuating trend of medical travel. Analysis of medical 
travel vis-à-vis core health system dimensions required to 
achieve UHC identified major shortages in the areas of 
health infrastructure and technology. At the same time, 
coverage of (more limited) services that the countries are 
able to provide is exceptionally high. While Tuvalu and the 
Maldives were found to be the top importers of healthcare, 
and experienced the most significant growth in medical 
travel, this appears to be due to the public funding avail-
able to facilitate this. Although their approach, design and 
performance were slightly different, the two public schemes 
in Tuvalu and the Maldives suggest how an increase in 
access to health services may be achieved through medical 
travel. This study suggests that strategic importing of health 
services could be a promising mechanism to help SIDS 
achieve UHC.
Much analysis in medical travel literature has identified 
that it is growing, although at a slower pace than origi-
nally projected, with specific regional and heterogeneous 
patterns, and that it is a diverse industry.8 12–14 The analysis 
presented here is the first of medical travel among SIDS, 
and findings confirm this heterogeneous pattern.15 Analysis S
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of data from 140 economies in the travel and tourism 
competitiveness report of 2011 indicates that the industry 
has witnessed contractions since 2009 due to the global 
economic crisis, volatile oil prices, climatic disturbances, 
multiple security incidents and pandemics16 may explain 
the non-linear growth of medical travel across SIDS.
The SIDS analysed here generally lacked health 
infrastructure and technologies that will affect their 
capacity to achieve UHC. However, this is not inherent 
in all SIDS. Countries such as Belize ($0.1 million), 
Barbados ($2.4 million), Cape Verde ($0.01 million), 
Tonga ($0.006 million) and Tuvalu ($0.004 million) have 
Figure 3 Health-related travel against health service coverage indicators, 2007– 2014.
Figure 4 Average expenditure on health-related travel per capita versus health financing structure, 2003–2013.
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innovatively earned an income from health-related travel 
as well. According to the BOP manual, income covers 
two types of transactions between residents and non-res-
idents; compensation of employees paid to non-resident 
workers and investment income receipts and payments 
on external financial assets and liabilities. Reports of 
income generated directly by medical tourism in SIDS is 
very rare except for few cases such as by the island state 
of Penang in Malaysia, which contributes more than 50% 
of the country’s medical tourism market with seven of 
its hospitals actively involved in medical tourism.17 The 
growth of medical tourism in Barbados serving the Carri-
bean, Mexican and the British patients have also been 
highlighted, although monetary benefits have not been 
mentioned.18 These bidirectional flows of trade in health 
services deserve greater investigation to understand 
better the factors that allow SIDS to act as exporters of 
services.
Figure 5 Average health-related travel per capita versus health workforce, 2005–2013.
Figure 6 Expenditure on health-related travel per capita versus density of health infrastructure and technologies, 2013.
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The three largest ‘bubbles’, representing high levels of 
per capita medical travel spending, by Tuvalu ($156.9), 
the Maldives ($113.2) and the Seychelles ($100.8) had 
public funds available for medical travel, which implies 
that medical travel is facilitated by the availability of 
government subsidy. The Tuvalu Medical Treatment 
Table 5 Description of public schemes for medical travel in Tuvalu and Maldives
Tuvalu model Maldives model
Is there a national policy 
to fund medical travel 
overseas?
Tuvalu Medical Treatment Scheme (TMTS): medical 
referral scheme with Fiji introduced in 200519 and 
partner of medical treatment scheme with New 
Zealand.
‘Husnuvaa Aasandha’: universal healthcare 
programme in the Maldives that subsidises for 
overseas treatment, introduced in 2012.
How the programme works:
  Approach Multilateral: government-to-government 
programme. Other countries participating in the 
medical treatment scheme with New Zealand are 
Fiji, Kiribati, Tonga and Vanuatu
Bilateral: government-to-foreign provider 
programme. Participating countries are the 
Maldives, India and Sri Lanka.
The Aasandha office is established in Sri Lanka 
to serve Maldivians seeking treatment in Sri 
Lanka under the government subsidy.
  Goal Provide access to specialist care not available 
for citizens in Fiji, Kiribati, Tonga, Vanuatu and 
Tuvalu. Also provides a visiting medical specialist 
programme.
Provide access to services unavailable in the 
Maldives.
  Management of the 
scheme
Each country maintains an incountry overseas 
referral committee (ORC) that manages the 
scheme, handling all aspects of the referral until 
the patient arrives overseas.
The scheme is implemented by an insurance 
company, Aasandha Private Ltd at a contracted 
price of 2750 Maldivian Rufiyah (MRFf per 
person for the first year (2012)
  Financing Participating countries make annual contributions 
for the scheme through bilateral discussions.
Paid directly to the contracted providers through 
the Maldivian government general revenues on a 
fee for service basis.
  Purchasing Health specialists/providers are under contract 
with New Zealand’s International Aid & 
Development Agency
Specialist teams from New Zealand are sent to 
partner countries of the scheme.
Through contracted hospitals in India and Sri 
Lanka on a fee-for-service basis. Contracts are 
annually renewed.
Scheduled visits by mobile teams of specialists 
are done on a regular basis.
  Eligibility (clinical/
non-clinical)
Referrals are made based on appropriate specialist 
advice and supported by the participating 
country’s ORC.
There is good prognosis for the patient living and 
improved quality of life for at least 5 years after 
treatment according to clinical evidence and 
advice.
Overseas referrals are prescribed by a public 
sector physician.
  Exclusions Chronic cardiac failure, chronic renal failure, 
chronic lung conditions, chronic neurological 
conditions and conditions requiring heart, renal or 
bone marrow transplants are excluded.
Patients who have significant medical conditions 
other than that for which they are being referred 
(eg, coexisting renal disease) and/or conditions 
that will incur ongoing costs that are unable to be 
met by partner government health funds.
Offers a comprehensive package with few 
exclusions such as cosmetic surgeries, 
dental, nutritional supplements, treatments for 
addictions, counselling, weight loss, abortions, 
infertility and complimentary medicines.
  Expenses covered Treatment cost, food, accommodation, small 
allowance and travel expenses.
Treatment costs, tickets for patient and one 
caregiver.
  Coverage statistics In 2013 TMTS spent $A 2.1 million, which is 
44.5% of the health budget, where 99 patients 
(approximately 0.9% of the population) were 
subsidised by the government.
In 2013, Aasandha spent US$ 4.8 million 
on 3456 visits (approximately 0.9% of the 
population) that were subsidised for medical 
travel.
  Tradeoffs Sacrifices half the health budget that could be 
used for other health services such as primary 
healthcare.  
High out-of-pocket expenditure on medical 
travel by patients who choose to self-fund their 
treatments.
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Scheme (TMTS) signed between Tuvalu and overseas 
hospitals in the region spent 44.5% of its health budget 
on overseas treatment in 2013,19 while the Maldives under 
its scheme ‘Aasandha’ spent $11.6 million on subsidised 
travel in Indian and Sri Lankan hospitals in 201220 and 
treatments worth $1.53 million per annum are funded by 
the Seychelles government.21 Evidence has shown that 
public financing for health has the potential to reduce 
inequities, and an investigation of equity measures with 
regard to public financing of overseas treatment in the 
Maldives has been reported elsewhere. Investments in 
highly technological specialist care in very small popula-
tions, and geographical formations of these island nations 
may not be economically feasible. Yet, the cost-effective-
ness of public financing for health-related travel needs to 
be explored and compared with alternatives such as the 
establishment of services locally.
The examples of Tuvalu and the Maldives demonstrate 
that access to health services that were not feasible to be 
established in these countries can be provided through 
the import of health services. Analysis of claims data from 
the National Social Protection Agency of the Maldives 
showed that the number of beneficiaries subsidised for 
treatment abroad increased by 199% and average expen-
diture per beneficiary increased 49.7% during 2010 and 
2013.22 The TMTS, introduced in 2005, has increased 
its expenditure from approximately $0.3 million to 
$1.5 million in 2013, and a preliminary analysis of the 
expected reforms of the scheme suggests that a per-pa-
tient saving of $A 15 000 can be achieved by the govern-
ment of Tuvalu by referring cardiac cases to India.19 
These public schemes were different in approach, design 
and coverage. With a direct government to foreign 
provider approach, the Maldives appears to be providing 
a more comprehensive set of services to a greater number 
of patients at a smaller per capita health budget, while 
the multilateral approach by Tuvalu is likely to have 
contributed to reducing the burden of OOP maintained 
at an average of 0.1% over the past decade. The lack of a 
private sector in the Tuvaluan health system and predom-
inant public funding of health services also contribute 
to this. Both the schemes have attracted critique from 
international organisations such as the IMF and WB, and 
policy documents of Tuvalu and the Maldives have high-
lighted the opportunity cost of these schemes. These costs 
include: lost incentive to improve or expand access to the 
domestic health system, lost continuums of care, maldis-
tribution and skill mix imbalances of health workers23 and 
cost of complications that has to be borne by domestic 
health systems.24 In the Maldives, the cost of the scheme 
itself is very high, whereby the median expenditure per 
beneficiary has increased from $605 in 2010 to $739 in 
2013.25 The Maldives health policy notes by the WB ques-
tioned the fiscal sustainability of the scheme in the long 
run calling for negotiated close-ended package rates with 
foreign providers and for targeted subsidies for highly 
complex treatments only.20 The health master plan of 
the Maldives 2016–2025 has also cautioned the tendency 
of overutilisation of services due to the perception that 
the current scheme is ‘unlimited’, which has resulted 
in inefficient use of resources especially in the absence 
of a gate-keeping system.26 The IMF in its latest country 
report of Tuvalu noted the potential overspending of 
the TMTS programme and advised the authorities to 
improve the cost-effectiveness of its policy. The strategic 
health plan of Tuvalu 2009–2018 further noted that the 
TMTS put a significant drain on public resources threat-
ening its ability to maintain other health services in the 
country.27 28 Hence, maintaining a balance in the ratio of 
expenditure on preventive and curative healthcare is vital 
if import of health services is implemented as a solution 
to achieve UHC.
This study relies on international indicators that have 
limitations in methodology and application in different 
countries. A review of literature that used indicators as 
a measurement of health system performance showed 
that there were differences in the adoption of indica-
tors by developing and developed countries29 and the 
composition of SIDS in this study included high-in-
come, upper-middle-income, low-and-middle-income 
and low-income countries, which may limit the general-
isability of study findings. We address the issue of data 
in online supplementary annex 1, which details data 
sources used by the SIDS to report to the IMF. Data on 
the volume of travel may have given better insight on 
trends in medical travel. The IMF member states have 
also used combination of methods to report travel data, 
which may result in underestimation or over-estimation 
of travel data in these countries. However, this study has 
used panel data of travel expenditures of 10 years and, 
where possible, panel data of indicators too, to minimise 
such overestimations and underestimations reflected in 1 
or 2 years of data.
ConClusIon
The trend in health-related travel among SIDS has over 
the last 10 years followed the global trend—rising yet 
heterogeneous. The pattern also demonstrated a vola-
tility to global events, a factor that needs to be taken into 
consideration by SIDS considering import as a mecha-
nism to increase access to health services.
SIDS generally lacked the health technologies needed 
to achieve UHC. The two island states with the highest per 
capita expenditures on the import of health services had 
publicly funded schemes to manage the process. Assess-
ment of the Tuvaluan and Maldivian public schemes to 
subsidise medical travel have demonstrated that access 
to specialised, technology-driven health services can be 
increased through import of health services. Our find-
ings suggest that import of health services is a potential 
mechanism to help achieve UHC but highlight the need 
for due diligence over cost, equity and quality control.
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